Nutrient quality
Chelavite suggests a useful chromium chelate, though its binding ligand is not identified. Targeted amounts support the concept, while incomplete chelate detail and chitosan’s absorption effects are trade-offs.
Analysis
The three-capsule serving combines 300 mcg Chelavite chromium with 1.5 g LipoSan Ultra chitosan. Chromium targets glucose handling, while chitosan is intended to bind some dietary fat in the digestive tract.
Both active amounts are clear, but the chitosan serving is modest and expected weight effects are limited without dietary changes. Binding activity can also reduce absorption of fat-soluble vitamins and some medicines when taken together.
Forty servings and three capsules make the formula less convenient than a simple chromium capsule. The combination is more coherent for weight management than chromium alone, but safety depends on careful timing.
Pros
Uses a named chromium chelate Provides 1.5 g branded chitosan Clearly states both active amounts Combines two relevant mechanisms
Cons
Requires three capsules Provides only 40 servings Chitosan appears modestly dosed Can complicate medicine and nutrient timing
Warnings
Chitosan may reduce absorption of fat-soluble vitamins and medicines; separate it according to pharmacist or label guidance. Verify the chitosan source and allergen statement if shellfish allergy is a concern. Chromium may add to insulin or other glucose-lowering medicines and increase low-blood-sugar risk.
